Ingmar Bruns

Chief Medical Officer, Zentalis Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.0M

Companies

Latest trade

Feb 9, 2026

Companies

Zentalis Pharmaceuticals, Inc.Chief Medical Officer −$0.0M

Trades

ZNTL Sold 335 shares at $2.39 $0.0M Feb 9

ZNTL Sold 2,962 shares at $2.43 $0.0M Feb 6

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.